(Q45746106)

15 December 2017

title

Mixed cryoglobulinaemia associated with hepatitis C virus infection: a predictor factor for treatment with interferon? (English)

1 reference

15 December 2017

1 reference

6

Rizzetto M

1 reference

15 December 2017

author name string

Pellicano R

1

1 reference

15 December 2017

Marietti G

2

1 reference

15 December 2017

Leone N

3

1 reference

15 December 2017

Arena V

4

1 reference

15 December 2017

Palmas F

5

1 reference

15 December 2017

Ponzetto A

7

1 reference

15 December 2017

publication date

1 November 1999

1 reference

15 December 2017

Journal of Gastroenterology and Hepatology

published in

1 reference

15 December 2017

volume

14

1 reference

15 December 2017

issue

11

1 reference

15 December 2017

page(s)

1108-1111

1 reference

15 December 2017

The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.1999.02015.X

A role for hepatitis C virus infection in type II cryoglobulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.1999.02015.X

Factors predictive of a beneficial response to therapy of hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.1999.02015.X

Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.1999.02015.X

Classification of chronic hepatitis: diagnosis, grading and staging

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.1999.02015.X

Histological grading and staging of chronic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.1999.02015.X

Transection of the oesophagus for bleeding oesophageal varices

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.1999.02015.X

Clinical, virological and epidemiological basis for the treatment of chronic non-A, non-B hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.1999.02015.X

A high prevalence of antibody to the hepatitis C virus in patients with hepatocellular carcinoma in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.1999.02015.X

Hepatitis C: a multifaceted disease. Review of extrahepatic manifestations

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.1999.02015.X

Hepatitis C virus and mixed cryoglobulinaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.1999.02015.X

The management of chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.1999.02015.X

Other approaches to the treatment of chronic viral hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.1999.02015.X

Ribavirin and interferon-alpha combination therapy vs interferon-alpha alone in the retreatment of chronic hepatitis C: a randomized clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.1999.02015.X

Long-term results of therapy with interferon alpha for cryoglobulinemia associated with hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.1999.02015.X

10.1046/J.1440-1746.1999.02015.X

21 January 2018

Identifiers

DOI

1 reference

15 December 2017

1 reference

15 December 2017